Dehydrocholic acid

Dehydrocholic Acid Overview

Dehydrocholic acid is a synthetic, oxidized bile acid derivative (chemically designated as 3,7,12-trioxo-5beta-cholan-24-oic acid). Chemically, it belongs to the class of bile acids, alcohols, and derivatives within the steroids and steroid derivatives superclass. It is synthesized industrially via the chemical oxidation of natural cholic acid using chromic acid.

In clinical gastroenterology and hepatology, Dehydrocholic acid is classified as a hydrocholeretic agent, cholagogue, and laxative (ATC categories for bile acids, cholagogues, and intestinal agents). Unlike primary endogenous bile acids (such as cholic acid and chenodeoxycholic acid), Dehydrocholic acid stimulates the secretion of a high-volume, low-viscosity, water-rich bile (a process termed hydrocholeresis) rather than increasing bile acid output. Historically, it was formulated as single-entity tablets (e.g., Dycholium) and prescription combination products (e.g., Regubil, Acidobyl, Medichol) containing digestive enzymes (pancrelipase, pepsin) or prokinetics (metoclopramide) for the symptomatic management of functional dyspepsia, biliary stasis, and mild constipation. However, many health authorities (including Health Canada and the US FDA) have discontinued or restricted over-the-counter approvals for Dehydrocholic acid due to the availability of safer, more effective hepatobiliary therapeutics.

What Is Dehydrocholic Acid and How Does It Work?

Dehydrocholic acid acts primarily through osmotic hydrocholeresis and canalicular tight-junction alteration.

Its primary physiological, biochemical, and cellular mechanisms include:

• Stimulation of Hydrocholeresis: Following oral administration, Dehydrocholic acid is absorbed and excreted into bile canaliculi. Due to its tri-keto structure, it exhibits low micellar binding capacity compared to primary bile acids. As a result, it generates an osmotic gradient that draws water and inorganic electrolytes into the biliary tree, producing a high volume of diluted, watery bile.
• Reduction of Biliary Lipid and Phospholipid Secretion: Because Dehydrocholic acid-produced bile lacks normal micellar formation properties, it blunts the biliary secretion of endogenous cholesterol and phospholipids, flushing the bile ducts without concentrating biliary lipids.
• Canalicular Tight-Junction Permeability Alteration: Research indicates that Dehydrocholic acid increases the paracellular permeability of canalicular membrane tight junctions, facilitating direct fluid exchange between hepatic plasma and biliary fluid.
• Mitochondrial Kinase Interaction: In vitro target studies suggest Dehydrocholic acid acts as an inhibitor of mitochondrial [pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3 (PDK3).

Is Dehydrocholic Acid FDA Approved?

Yes, Dehydrocholic Acid was originally approved by the US FDA prior to 1982 (under entries such as NDA 002161) as a prescription hydrocholeretic agent for biliary flushing and functional dyspepsia. However, in 1990, under 21 CFR 310.545, the FDA reclassified Dehydrocholic Acid as non-monograph (unapproved) for over-the-counter (OTC) laxative and digestive aid use due to inadequate clinical proof of efficacy. Commercial distribution of prescription formulations has since been voluntarily discontinued in the United States and Canada in favor of modern therapeutic bile acids (such as ursodeoxycholic acid).

What Was Dehydrocholic Acid Used For?

• Historical symptomatic treatment of functional dyspepsia, epigastric bloating, and impaired fat digestion.
• Historical hydrocholeretic therapy to flush the biliary tree in non-obstructive biliary stasis and chronic cholecystitis.
• Adjunctive laxative therapy for mild, transient constipation (historically co-formulated with docusate sodium or bile salts).

Before Taking Dehydrocholic Acid: Contraindications & Precautions

Strictly contraindicated in individuals with complete mechanical biliary tract obstruction (e.g., choledocholithiasis, biliary strictures), as inducing hydrocholeresis behind an obstruction can cause acute gallbladder distension, severe biliary colic, and ductal rupture. Do not use in patients with severe active hepatic insufficiency, acute hepatitis, hepatic encephalopathy, acute cholecystitis, acute appendicitis, or active gastrointestinal obstruction.

Who Should Not Take Dehydrocholic Acid?

• Patients with complete mechanical biliary tract obstruction (e.g., choledocholithiasis or biliary strictures), as inducing hydrocholeresis behind a complete blockage causes acute gallbladder distension, severe biliary colic, and potential ductal rupture.
• Patients with severe active hepatic insufficiency, severe hepatitis, or hepatic encephalopathy.
• Individuals with acute cholecystitis, acute appendicitis, or active gastrointestinal obstruction.
• Patients with known hypersensitivity to bile acid salts or formulation excipients.

Dehydrocholic Acid, Pregnancy & Fertility

Dehydrocholic acid is a synthetic oxidized bile acid. Adequate, well-controlled reproductive safety studies in pregnant women are lacking. It should be avoided during pregnancy and lactation unless specifically deemed necessary by a physician.

Tell Your Doctor Before Taking Dehydrocholic Acid

Inform your gastroenterologist if you have a history of gallstones, jaundice, liver disease, severe abdominal pain, or inflammatory bowel disease. Disclose all concurrent prescription and over-the-counter medications.

Dehydrocholic Acid Dosage & Administration

Dehydrocholic Acid is a discontinued, unapproved/withdrawn medication in North America, rendering standard clinical dosing guidelines obsolete. Formulated historically as oral tablets (250 mg to 500 mg) taken 2 to 3 times daily after main meals with a full glass of water. It is no longer manufactured or available for legal medical administration.

Standard Dehydrocholic Acid Dosing

• Historical Oral Adult Dosing (Dyspepsia / Hydrocholeresis): Historical single-entity oral formulations (e.g., Dycholium) were administered at doses of 250 mg to 500 mg taken orally 2 to 3 times daily following meals. Standardized modern dosing guidelines are obsolete due to product discontinuations.

How Dehydrocholic Acid Was Administered

• Administered via the oral route in tablet, coated tablet, or delayed-release form.
• Doses were taken immediately after main meals with a full glass of water.

Dehydrocholic Acid Clinical Efficacy & Research

Biochemical research establishes that Dehydrocholic acid induces significant watery bile flow (hydrocholeresis) in mammalian models. However, because it does not form mixed micelles effectively, it fails to solubilize cholesterol or promote the dissolution of gallstones, unlike modern therapeutic bile acids such as ursodeoxycholic acid (UDCA). Clinical trials evaluating combination digestive formulations showed modest relief of non-ulcer dyspepsia, but these effects were largely attributed to co-formulated digestive enzymes (pancrelipase) and prokinetics rather than Dehydrocholic acid itself.

Dehydrocholic Acid Side Effects & Safety Profile

Common historical side effects included watery diarrhea, abdominal cramping, flatulence, nausea, and a mild pressure sensation in the right upper quadrant. Serious adverse risks included acute biliary colic, severe gallbladder distension, and profound fluid and electrolyte loss from unabsorbed intestinal bile acid salts. Holds no FDA Black Box Warning.

Common Dehydrocholic Acid Side Effects

• Gastrointestinal: Diarrhea, watery stools, abdominal cramping, flatulence, and nausea.
• Biliary pressure sensation or mild right upper quadrant discomfort.

Serious Dehydrocholic Acid Adverse Events

• Acute Biliary Colic & Gallbladder Distension: Severe pain secondary to increased biliary pressure in patients with undiagnosed partial or complete bile duct obstruction.
• Severe Electrolyte & Fluid Loss: Profuse diarrhea and secondary dehydration from unabsorbed intestinal bile acid salts.
• Severe hypersensitivity reactions.

Managing Dehydrocholic Acid Side Effects

Discontinue medication immediately if severe abdominal pain, watery diarrhea, or jaundice develops. Provide oral or intravenous fluid rehydration if significant diarrhea occurs.

Dehydrocholic Acid Drug Interactions & What to Avoid

Bile acid sequestrants (e.g., cholestyramine, colestipol) bind Dehydrocholic Acid in the intestinal lumen, completely preventing its gastrointestinal absorption and hydrocholeretic action. Antacids and proton pump inhibitors may alter the dissolution rate of enteric-coated or delayed-release tablet formulations. Avoid alcohol consumption, as it exacerbates underlying hepatic inflammation and gastric mucosal irritation.

Dehydrocholic Acid Drug-Drug Interactions

• Bile Acid Sequestrants (e.g., Cholestyramine, Colestipol): Bind Dehydrocholic acid in the intestinal lumen, completely preventing its gastrointestinal absorption and hydrocholeretic action.
• Antacids & Proton Pump Inhibitors: May alter the dissolution rate of enteric-coated or delayed-release tablet formulations.

Dehydrocholic Acid, Food & Alcohol

Avoid taking with high-fat meals if biliary obstruction is suspected. Alcohol consumption should be avoided as it exacerbates hepatic inflammation and gastric mucosal irritation.

Dehydrocholic Acid: Missed Dose, Overdose & Storage

Dosing schedules are obsolete due to market withdrawal. Acute overdose causes severe watery diarrhea, intense abdominal cramping, fluid and electrolyte depletion, and acute hepatic congestion, requiring immediate emergency evaluation and supportive fluid rehydration.

Missed Dose of Dehydrocholic Acid

If using legacy combination formulations and a dose is missed, take it with the next meal. If it is almost time for your next meal, skip the missed dose. Do not take double doses.

Dehydrocholic Acid Overdose & Emergency

Acute overdose causes severe watery diarrhea, intense abdominal cramping, fluid and electrolyte depletion, and acute hepatic congestion. Seek immediate medical evaluation and supportive fluid rehydration.

How to Store Dehydrocholic Acid

Store solid oral dosage forms at controlled room temperature between 15 degrees C and 30 degrees C (59 degrees F to 86 degrees F). Protect from excessive heat, light, and moisture. Keep strictly out of reach of children.

Dehydrocholic Acid Patient Management & Monitoring

Historical protocols required a baseline liver function panel (ALT, AST, alkaline phosphatase, total bilirubin) and an abdominal ultrasound prior to initiation to exclude mechanical bile duct obstruction or gallstone impaction. During treatment, monitor for clinical resolution of dyspeptic symptoms and evaluate immediately for signs of severe right upper quadrant pain (biliary colic), dark urine, or pale stools.

Tests Before Starting Dehydrocholic Acid

• Baseline liver function panel (ALT, AST, alkaline phosphatase, total bilirubin).
• Abdominal ultrasound to exclude mechanical bile duct obstruction or gallstone impaction.

Monitoring During Dehydrocholic Acid Treatment

Evaluate resolution of dyspeptic symptoms and monitor for signs of biliary colic or bowel dysfunction.

Dehydrocholic Acid Do’s and Don’ts

• Do take doses with food and water if prescribed legacy combinations.
• Do notify your physician immediately if dark urine, pale stools, or severe right upper quadrant pain occurs.
• Do not take if you have known bile duct obstruction or gallstones.
• Do not use discontinued over-the-counter preparations without medical oversight.

Frequently Asked Questions

References

• DrugBank Database – Dehydrocholic Acid Clinical Profile (DB11622)
• Classyfire Database – Bile Acids, Alcohols and Derivatives Chemical Taxonomy Profile

Legal Disclaimer

The detailed medical and chemical information provided on this specific web page is intended strictly for educational and informational purposes regarding complex pharmacological mechanisms. It absolutely does not constitute professional medical advice, medical diagnosis, or specific treatment recommendations. Always consult a licensed healthcare provider before making any personal decisions regarding complex medical conditions, medication adjustments, or dietary changes.